Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
MSL “GROWTH”…Within the role and BEYOND
Summary
In this episode, Danielle Day, Senior Medical Director at Sobe North America, joins Tom Caravela to share her journey from academia to the MSL role. Danielle discusses her transition, highlighting her first successful interview and hiring experience, and her progression at AstraZeneca. She emphasizes the significance of being proactive, creative, and engaging internally across functions. The conversation explores career paths, the importance of skill development over job titles, and understanding various roles to manage expectations. Danielle provides insights on transitioning within the industry, gaining diverse experiences, and moving into management, underscoring perseverance and mentorship in career growth.
Danielle Day, Senior Medical Director, Immunology, Rare Disease at Sobi - North America discusses how to grow within the MSL role and beyond.
Danielle shares….
👉 Her career progression and how she GREW her career
👉 The importance of being proactive and collaborative
👉 How to take an out of the box approach
👉 Why you need to ask good questions throughout your career
👉 Looking behind the curtain to see how the sausage is made
Medical Science Liaison, career progression, transitioning in pharma, skill development, mentorship in career growth
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO